Aigen Investment Management, LP Myriad Genetics Inc Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$19.92 - $31.6 $378,639 - $600,652	-19,008 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$12.16 - $19.77 $614,250 - $998,661	-50,514 Reduced 72.66%	19,008 $376,000
Q3 2020 Nov 06, 2020	BUY	$11.25 - $14.75 $782,122 - $1.03 Million	69,522 New	69,522 $907,000
Q2 2020 Aug 10, 2020	SELL	$10.69 - $16.49 $168,132 - $259,354	-15,728 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$9.78 - $29.53 $151,717 - $458,098	15,513 Added 7215.35%	15,728 $225,000
Q4 2019 Feb 04, 2020	BUY	$20.93 - $35.1 $4,499 - $7,546	215 New	215 $6,000

227

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.